These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 6169607)

  • 21. Tests for hemostasis and their relevance to venous thrombosis.
    Johnston DW; Scott AA; Glynn MF
    Can J Surg; 1980 Jul; 23(4):373-80. PubMed ID: 6968239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Soluble fibrin monomer complexes in thromboembolism].
    Gryglik J
    Przegl Lek; 1982 Sep; 39(8):551-3. PubMed ID: 6753042
    [No Abstract]   [Full Text] [Related]  

  • 23. [Thrombosis-inducing activity (TIA) in plasma of a patient with lung cancer, which disappeared after radiotherapy].
    Hayashi S; Ogino H; Nomoto Y; Kawasaki M; Miyagawa Y; Hirano H; Tanaka K; Nakanishi M; Ichinose Y; Yagawa K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Sep; 30(9):1724-7. PubMed ID: 1447849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [D-dimer determination in suspected deep venous thrombosis or lung embolism].
    Bounameaux H
    Praxis (Bern 1994); 1997 Nov; 86(47):1860-4. PubMed ID: 9480504
    [No Abstract]   [Full Text] [Related]  

  • 25. [Comparative fibrinogen determination by artificial in vitro fibrinogen lysis with regard to fibrinogen split products].
    Kätzel R; Brunner HP; Bohr A
    Z Med Lab Diagn; 1981; 22(3):138-43. PubMed ID: 7293326
    [No Abstract]   [Full Text] [Related]  

  • 26. [Products of degradation of fibrinogen in surgical patients].
    Golovastova GI; Guseĭnov ChS
    Lab Delo; 1975; (6):368-71. PubMed ID: 51128
    [No Abstract]   [Full Text] [Related]  

  • 27. [Anatomical and medical laboratory parallels of various forms of thrombus formation].
    Angelov A; Alachverdjan RP
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(3):414-22. PubMed ID: 2444516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progress in the measurement of circulating fibrinogen derivatives.
    Wilner GD
    Prog Clin Pathol; 1984; 9():15-45. PubMed ID: 6229812
    [No Abstract]   [Full Text] [Related]  

  • 29. Markers of hemostatic system activation in pulmonary embolism. Changes during and after cessation of anticoagulant treatment.
    de Raucourt E; Meyer G; Landais P; Gouaref Z; Morinet P; Monge F; Sors H; Fischer AM
    Blood Coagul Fibrinolysis; 2000 Apr; 11(3):249-53. PubMed ID: 10870805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
    Koga S
    Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The value of laboratory tests in the diagnosis of venous thromboembolism.
    Sié P
    Haematologica; 1995; 80(2 Suppl):57-60. PubMed ID: 7628772
    [No Abstract]   [Full Text] [Related]  

  • 32. [Alteration of serum levels of endotoxin, polymorphonuclear leukocyte elastase, and the molecular markers of the coagulation and fibrinolytic system in the patients with esophageal cancer and lung cancer before and following operation].
    Moriyama H; Hirata S; Kubo Y
    Rinsho Byori; 1995 Mar; 43(3):233-7. PubMed ID: 7745828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of a rapid D-dimer blood test in the diagnostic work-up for pulmonary embolism: a management study.
    de Groot MR; van Marwijk Kooy M; Pouwels JG; Engelage AH; Kuipers BF; Büller HR
    Thromb Haemost; 1999 Dec; 82(6):1588-92. PubMed ID: 10613639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reactivity of soluble fibrin assays with plasmic degradation products of fibrin and in patients receiving fibrinolytic therapy.
    McCarron BI; Marder VJ; Francis CW
    Thromb Haemost; 1999 Dec; 82(6):1722-9. PubMed ID: 10613661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The mutation in fibrinogen Bicêtre II (gamma Asn308-->Lys) does not affect the binding of t-PA and plasminogen to fibrin.
    Grailhe P; Boyer-Neumann C; Haverkate F; Grimbergen J; Larrieu MJ; Anglés-Cano E
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):679-87. PubMed ID: 8292717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fibrinogen catabolism within the procoagulant VX-2 tumor of rabbit lung in vivo: Effluxing fibrin(ogen) fragments contain antiangiogenic activity.
    Hatton MW; Southward SM; Legault KJ; Ross BL; Clarke BJ; Bajzar L; Blajchman MA; Singh G; Richardson M
    J Lab Clin Med; 2004 Apr; 143(4):241-54. PubMed ID: 15085083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modifications of coagulation and fibrinolytic parameters in laparoscopic cholecystectomy.
    Vecchio R; Cacciola E; Martino M; Cacciola RR; MacFadyen BV
    Surg Endosc; 2003 Mar; 17(3):428-33. PubMed ID: 12457211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The effect of plasmapheresis on hemostasis in lung cancer patients].
    Tarabykin AA; Kliachkin BM; Basargin ST
    Ter Arkh; 1990; 62(9):108-11. PubMed ID: 2281391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparative study of various rapid methods of determining fibrinogen transformation products in the diagnosis of intravascular coagulation and fibrinolysis].
    Lychev VG; Momot AP; Cherkashin GV
    Ter Arkh; 1984; 56(6):106-9. PubMed ID: 6474366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravascular and peritoneal coagulation and fibrinolysis in horses with acute gastrointestinal tract diseases.
    Collatos C; Barton MH; Prasse KW; Moore JN
    J Am Vet Med Assoc; 1995 Aug; 207(4):465-70. PubMed ID: 7591947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.